SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-24-138311
Filing Date
2024-05-14
Accepted
2024-05-14 16:38:13
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d840153d424b5.htm 424B5 374581
2 GRAPHIC g840153g02k02.jpg GRAPHIC 48063
3 GRAPHIC g840153g50x50.jpg GRAPHIC 40086
4 GRAPHIC g840153g59k59.jpg GRAPHIC 54354
  Complete submission text file 0001193125-24-138311.txt   560112
Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Filer) CIK: 0001737287 (see all company filings)

IRS No.: 823562771 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-277951 | Film No.: 24945103
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)